Northern Trust’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Buy |
164,417
+11,972
| +8% | +$27.7K | ﹤0.01% | 3739 |
|
|
2025
Q1 | $1.19M | Buy |
152,445
+46,484
| +44% | +$363K | ﹤0.01% | 3203 |
|
|
2024
Q4 | $495K | Buy |
105,961
+9,154
| +9% | +$42.7K | ﹤0.01% | 3661 |
|
|
2024
Q3 | $522K | Buy |
96,807
+68,748
| +245% | +$371K | ﹤0.01% | 3572 |
|
|
2024
Q2 | $247K | Buy |
28,059
+7,642
| +37% | +$67.4K | ﹤0.01% | 3783 |
|
|
2024
Q1 | $240K | Sell |
20,417
-4,652
| -19% | -$54.7K | ﹤0.01% | 3834 |
|
|
2023
Q4 | $282K | Buy |
25,069
+4,799
| +24% | +$54K | ﹤0.01% | 3752 |
|
|
2023
Q3 | $137K | Hold |
20,270
| – | – | ﹤0.01% | 3933 |
|
|
2023
Q2 | $184K | Sell |
20,270
-27
| -0.1% | -$245 | ﹤0.01% | 3859 |
|
|
2023
Q1 | $131K | Buy |
20,297
+1,191
| +6% | +$7.69K | ﹤0.01% | 4007 |
|
|
2022
Q4 | $121K | Hold |
19,106
| – | – | ﹤0.01% | 4029 |
|
|
2022
Q3 | $118K | Hold |
19,106
| – | – | ﹤0.01% | 4061 |
|
|
2022
Q2 | $169K | Sell |
19,106
-799
| -4% | -$7.07K | ﹤0.01% | 3987 |
|
|
2022
Q1 | $168K | Hold |
19,905
| – | – | ﹤0.01% | 4190 |
|
|
2021
Q4 | $203K | Sell |
19,905
-2,316
| -10% | -$23.6K | ﹤0.01% | 4190 |
|
|
2021
Q3 | $432K | Buy |
22,221
+8,272
| +59% | +$161K | ﹤0.01% | 3818 |
|
|
2021
Q2 | $245K | Hold |
13,949
| – | – | ﹤0.01% | 4065 |
|
|
2021
Q1 | $166K | Buy |
13,949
+1,575
| +13% | +$18.7K | ﹤0.01% | 4159 |
|
|
2020
Q4 | $213K | Buy |
+12,374
| New | +$213K | ﹤0.01% | 3946 |
|